EnteroBiotix begins phase 2 study of candidate drug EBX-102
Clinical trial involves patients with liver cirrhosis and hepatic encephalopathy
Read More
Tag: ebx-102
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
